These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 3229037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
    Gerasimov G, Chernova T, Goncharov N.
    Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463
    [Abstract] [Full Text] [Related]

  • 3. Hyperprolactinemia associated with chronic renal failure in the rat.
    Torres-Noriega J, Frohman LA.
    Horm Metab Res; 1986 Apr; 18(4):241-3. PubMed ID: 3710420
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.
    Quigley ME, Judd SJ, Gilliland GB, Yen SS.
    J Clin Endocrinol Metab; 1980 Jun; 50(6):994-8. PubMed ID: 7372794
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dopamine infusion enhances the adrenocorticotropic hormone and cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects.
    Moro M, Maraschini C, Cavagnini F.
    Gynecol Endocrinol; 1997 Jun; 11(3):155-62. PubMed ID: 9209895
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
    Tkachenko NN, Potin VV, Beskrovnyĭ SV, Nosova LG.
    Probl Endokrinol (Mosk); 1990 Jun; 36(2):35-40. PubMed ID: 2114023
    [Abstract] [Full Text] [Related]

  • 12. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
    Petraglia F, De Leo V, Nappi C, Facchinetti F, Montemagno U, Brambilla F, Genazzani AR.
    J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metoclopramide challenge: a measure of human lactotroph activity.
    Martin RH.
    Obstet Gynecol; 1983 Dec; 62(6):691-5. PubMed ID: 6633994
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prolactin and TSH response in functional tests in patients with primary hypothyroidism in a context of hyperprolactinemia].
    Chernova TO, Kolesnikova GS, Mudretsova SV, Serpukhovitin SIu, Goncharov NP, Gereasimov GA.
    Probl Endokrinol (Mosk); 1994 Dec; 40(5):16-8. PubMed ID: 7899431
    [Abstract] [Full Text] [Related]

  • 20. [Pregnancy in hyperprolactinemic patients].
    Ventz M, Puhlmann B, Knappe G, Gerl H, Lehmann R, Rohde W.
    Zentralbl Gynakol; 1996 Dec; 118(11):610-5. PubMed ID: 9082694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.